12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·Apr 7 at 05:05 PMADTX-12.82%LNAI-2.26%
09:00 ETDelonix Bioworks Announces Initiation of Phase 1 First-in-Human Clinical Trial of a Next-Generation MenB OMV Vaccine DX-104prnewswire·Mar 30 at 01:02 PMLABU-1.77%IBBQ+0.18%
Delonix Bioworks clears IND for DX-104 vaccine in China & Australia for MenB; Feb 6, 2026.Unusual Whales·Feb 6 at 12:33 PMIBBQ+0.18%FBT-0.16%
Lunai Bioworks discovers 3 Parkinson's subtypes, targets for $13B market. Exciting progress in precision therapeutics.Unusual Whales·Dec 9, 2025 at 12:46 PMRENB0.00%LNAI-2.26%
Lunai Bioworks shares are trading higher after the company announced the publication of Second-Generation Allogeneic Dendritic Cell Therapy Platform in the journal "Vaccines".benzinga_article·Nov 5, 2025 at 03:05 PMLNAI-2.26%RENB0.00%
Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy | LNAI Stock NewsStockTitan·Nov 5, 2025 at 02:22 PMLNAI-2.26%RENB0.00%
